arrow
W

Wenjuan Zhang

Tianjin Medical University General Hospital
H指数:40
被引数:4,927

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Pharmacokinetic-pharmacodynamic-efficacy modeling of the MDM2 inhibitor brigimadlin in glioblastoma patient-derived xenografts

MDM2抑制剂brigimadlin在胶质母细胞瘤患者源性异种移植模型中的药代动力学-药效学-疗效建模

2026-01-010
OA
Sitravatinib plus tislelizumab in locally recurrent or metastatic triple-negative breast cancer: a multi-cohort, single-arm, phase II clinical trial (SPARK Trial)

Sitravatinib联合tislelizumab治疗局部复发或转移性三阴性乳腺癌: 一项多队列,单臂,II期临床试验 (SPARK试验)

2025-12-190
OAAI
Precision treatment with artificial intelligence assisted subtyping enhances therapeutic efficacy in HR+/HER2− breast cancer: The LINUXtrial

人工智能辅助分型指导的精准治疗可提高HR+/HER2−乳腺癌的疗效:LINUX试验

2025-12-040
PRE
Window of opportunity evaluation of blood-brain barrier permeability heterogeneity within and across high-grade glioma patients

高分级胶质瘤患者内及患者间的血脑屏障通透性异质性窗口期评估

2025-10-010
PRE
Neoadjuvant cadonilimab plus FLOT chemotherapy in locally advanced gastric/gastroesophageal junction adenocarcinoma: A multicenter, phase 2 study

新辅助卡度尼利单抗联合FLOT化疗在局部晚期胃/胃食管结合部腺癌中的应用:一项多中心、II期研究

MED
IF11.8
2024-11-010
PRE
Factors Influencing the Central Nervous System (CNS) Distribution of the Ataxia Telangiectasia Mutated and Rad3-Related Inhibitor Elimusertib (BAY1895344): Implications for the Treatment of CNS TumorsS
2024-11-010
PRE